14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $60.86 $75.66 Friday, 3rd May 2024 CYTK stock ended at $65.27. This is 1.45% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.47% from a day low at $65.00 to a day high of $66.61.
90 days $60.86 $81.33
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Apr 06, 2021 $24.82 $25.13 $24.04 $24.15 656 627
Apr 05, 2021 $24.81 $25.36 $24.71 $25.13 794 237
Apr 01, 2021 $23.31 $24.48 $23.13 $24.44 605 541
Mar 31, 2021 $22.38 $23.59 $22.17 $23.26 831 084
Mar 30, 2021 $22.51 $23.02 $22.17 $22.33 487 346
Mar 29, 2021 $23.69 $23.72 $22.50 $22.69 497 635
Mar 26, 2021 $24.08 $24.65 $22.97 $23.87 467 567
Mar 25, 2021 $22.01 $24.25 $22.01 $24.00 922 671
Mar 24, 2021 $23.87 $24.69 $22.39 $22.40 699 444
Mar 23, 2021 $24.54 $24.89 $23.65 $23.69 1 154 870
Mar 22, 2021 $25.34 $25.72 $24.28 $24.86 652 965
Mar 19, 2021 $24.13 $25.18 $24.06 $24.86 2 455 376
Mar 18, 2021 $25.71 $25.82 $24.15 $24.33 1 298 681
Mar 17, 2021 $23.91 $25.73 $23.30 $25.68 909 892
Mar 16, 2021 $24.02 $25.19 $23.33 $23.88 1 041 453
Mar 15, 2021 $22.80 $24.63 $22.23 $24.29 1 406 320
Mar 12, 2021 $20.84 $22.84 $20.66 $22.82 1 001 679
Mar 11, 2021 $19.99 $20.54 $19.76 $20.30 1 546 580
Mar 10, 2021 $20.00 $20.49 $19.48 $19.70 943 831
Mar 09, 2021 $19.57 $20.37 $19.34 $19.69 2 212 031
Mar 08, 2021 $19.76 $20.20 $19.14 $19.19 1 151 808
Mar 05, 2021 $18.66 $20.02 $18.00 $19.68 1 912 291
Mar 04, 2021 $18.26 $19.12 $18.04 $18.57 1 012 100
Mar 03, 2021 $19.36 $19.98 $18.56 $18.82 537 347
Mar 02, 2021 $19.53 $19.94 $19.05 $19.42 605 916
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT